Partner Dan Shores will participate as a panelist in the session titled "Significant international post-pandemic IP policies. A worldwide review." at the 9th Annual International Bar Association (IBA) World Life Sciences Conference taking place June 1-2, 2023, in Washington, D.C. Dan's session will take place on the second day of the conference, Friday, June 2.
The pandemic triggered various threats to the patent system in various jurisdictions. Some of them were temporary and unharmful but others seem to sustain trends and intimidation against innovators, especially in some fields such as biotechnology. Dan and his co-panelists will analyze and comment on practices including potential restrictive patentability criteria, patent backlogs, compulsory licensing, weak patent enforcement, litigation strategies, and lack of regulatory data protection. The discussion will include the weight of the TRIPS waiver expansion and WHO pandemic treaty and the central role USTR have in determining IP policies which could have influence in the public and private sectors. The mRNA space, especially in the context of the global rollout of the vaccines, also intersects with ongoing global IP policy issues. In many ways, pandemic, also demonstrated how innovators and governments were able to make progress together to improve global health
A conference co-presented by the IBA Intellectual Property and Entertainment Law Committee, the IBA Technology Law Committee, and the IBA Healthcare and Life Sciences Law Committee, the IBA World Life Sciences Conference will highlight the quicker development cycles, innovative technologies, and ground-breaking technological and legal precedents. In a conference spanning two days, industry speakers and other legal experts will summarze these key developments featuring a dynamic roundtable session, and panels covering the different sectors of the healthcare and life sciences industry.
To learn more, and to register, please visit the 9th Annual IBA World Life Sciences Conference website.
